Skip to main content
Premium Trial:

Request an Annual Quote

Prolexys and Ariadne to Integrate Software, Database

NEW YORK, Nov. 16 (GenomeWeb News) - Ariadne Genomics and Prolexys Pharmaceuticals will pair their pathway-analysis tools to target the pharmaceutical research market, the companies said today


Under the terms of the agreement, Prolexys' Human Interactome Database, a collection of experimentally verified human protein-protein interactions, will be integrated with Ariadne's PathwayStudio and PathwayExpert pathway-analysis software.

The Prolexys database will be available from Ariadne Genomics for an additional fee to its commercial customers, Prolexys and Ariadne said.